Rosetta shares sell on a tough day for Wall Street

Rosetta Genomics picked a tough day to go public. Offering its shares on a day that saw the worst one-day drop in prices since 2001, the Israeli company garnered $26.3 million after selling shares at $7 each, 50 cents a share less than its lowest price range. Rosetta uses a computer algorithm to research microRNA gene sequences.

- read the report on Rosetta's IPO from Globes